Harvest Group Wealth Management, LLC Organon & Co. Transaction History

Harvest Group Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	SELL	$23.31 - $28.61 $256 - $314	-11 Reduced 8.03%	126 $3,000
Q3 2022 Nov 08, 2022	SELL	$23.4 - $34.25 $5,077 - $7,432	-217 Reduced 61.3%	137 $3,000
Q2 2022 Aug 04, 2022	BUY	$31.66 - $38.9 $8,104 - $9,958	256 Added 261.22%	354 $11,000
Q1 2022 Apr 21, 2022	SELL	$30.45 - $39.36 $7,064 - $9,131	-232 Reduced 70.3%	98 $3,000
Q4 2021 Jan 21, 2022	BUY	$28.67 - $37.13 $2,809 - $3,638	98 Added 42.24%	330 $10,000
Q3 2021 Nov 03, 2021	SELL	$28.63 - $35.64 $601 - $748	-21 Reduced 8.3%	232 $8,000
Q2 2021 Aug 02, 2021	BUY	$28.45 - $38.0 $7,197 - $9,614	253 New	253 $8,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.